Abstract
Introduction
In pediatric population (0–18 years), low-grade gliomas (PLGG) are the most frequent brain tumors and majority are amenable for surgical removal.
Patients and methods
A retrospective review of 198 children diagnosed with PLGG between 1980 and 2010 at HSJD was carried out. Several variables were studied to find prognostic factors related to the outcomes (progression-free survival (PFS) and overall survival (OS)).
Results
Median age at onset was 88.8 months (3.1 to 214.5 months, SD 53). Surgery was performed in 175 patients (88.4 %), achieving gross total resection (GTR) in 77 (44 %), subtotal resection (STR) in 87 (49.7 %), and 11 (6.3 %) biopsies. Pathological review classified 84 tumors as WHO grade I (48 %) and 89 as grade II (50.8 %). Adjuvant therapy (AT) was given to 75 patients (37.9 %), radiotherapy in 24 (12.1 %), chemotherapy in 33 (16.7 %), and combined in 18 (9.1 %). Sixteen patients (8.1 %) died, 89 (43.4 %) are alive with no evidence of disease, and 93 (47 %) alive with disease, median follow-up 65.2 months. Outcome is significantly correlated with age (p = 0001, worse OS for patients younger than 12 months) and extent of tumor resection (p < 0001). OS for GTR/STR/biopsy was >200, 154.3, and 101.9 months, respectively. Patients treated with AT presented worse OS/PFS (p < 0.001) than those not treated. Histology was non significantly related to outcomes.
Conclusion
In our series of PLGG, the best prognostic markers are tumor location (cerebellar) and the extent of tumor resection (GTR). Infants and patients who require adjuvant therapy because of tumor progression or recurrence have worse outcome.
Similar content being viewed by others
References
Ater J, Holmes E, Zhou T, et al (2012) Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children. J Clin Oncol 30(21):2641–2647
Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Markus K, et al (2014) Long-term outcome of 4040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatr Blood Cancer 61(7):1173–1179
Beebe DW, Ris MD, Armostrong FD, Fontanesi J, Mulhern R, Holmes E, Wisoff JH (2005) Cognitive and adaptative outcome in low grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptative functioning in national collaborative research studies (CCG 9891/POG 9130). J Clin Oncol 23:5198–5204
Bristol RE (2009) Low-grade glial tumors: are they all the same? Semin Pediatr Neurol 16(1):23–26
CBTRUS. Statistical Report (2005) Primary brain tumors in the United States, 1998–2002. Central Brain Tumor Registry of the United States, Hinsdale
Choi KC, Kwak SE, Kim JE, Sheen SH, Kang TC (2009) Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumors. Neurosci Lett 463(3):182–187
Colin C, Padovani L, Chappe C, Merciurio S, Scavarda D, Loundou A, et al (2013) Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution. Neuropathol Appl Neurobiol 39(6):693–705
Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, et al (1988) Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23:545–556
De Carli E, Kalifa CM, Raquin J, Lemerle J, Habrand J, Couanet D, et al (2010) Premature deaths and severe morbidity in 192 long-term survivors of pediatric pathway tumors (OPT): a 50-year study. J Clin Oncol 28:15s(suppl; abstr 9555)
Drake J, Singhal A, Kulkarni A, De Veber G, Cochrane D, Canadian Pediatric Neurosurgery Study Group (2012) Consensus definitions of complications for accurate recording and comparisons of surgical outcomes in pediatric neurosurgery. J Neurosurg Pediatr 10(2):89–95
Due-Tonnessen B, Lundar T, Egge A, Scheie D (2013) Neurosurgical treatment of low-grade cerebellar atrocytoma in children and adolescents: a single consecutive institutional series of 100 patients. J Neurosurg Pediatr 11(3):245–249
Fakhreddine M, Mahajan A, Penas-Prado M, Weinberg J, et al (2013) Treatment, prognosis factors and outcomes in spinal cord astrocytomas. Neuro-Oncology 15(4):406–412
Fernandez C, Figarella-Branger D, Girard N, et al (2003) Pilocytic astrocytomas in children: prognostic factors—a retrospective study of 80 cases. Neurosurgery 53:544–555
Fisher PG, Tihan T, Goldthwaite PT, et al (2008) Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer 51:245–250
Fouladi M, Wallace D, Langston JW, et al (2003) Survival and functional outcome of children with hypothalamic/chiasmatic tumors. Cancer 97:1084–1092
Fouladi M, Jenkins J, Burger P, et al (2001) Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neuro-Oncology 3:184–192
Gaiser T, Becker MR, Meyer J, Habel A, Siegelin MD (2009) P53-mediated inhibition of angiogenesis in diffuse low-grade astrocytomas. Neurochem Int 54(7):458–463
Gajjar A, Bhargava R, Jenkins JJ, Heideman R, Sanford RA, Langston JW, et al (1995) Low-grade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg 83:67–71
Gajjar A, Sanford RA, Heideman R, et al (1997) Low-grade astrocytoma: a decade of experience at St Jude Children’s Research Hospital. J Clin Oncol 15:2792–2799
Garzon M, Garcia G, Guillen A, Sunol M, Mora M, Cruz O (2013) Brain stem tumors in children and adolescents: single institutional experience. Childs Nerv Syst 29(8):1321–1331
Gelpi E et al (2005) Pleomorphic xanthoastrocytoma with anaplastic features presenting without GFAP immunoreactivity: implications for differential diagnosis. Neuropathology 25(3):241–246
Gnekow AK, Falkenstein F, Von Homstein S, Zwiener I, Berkefeld S, Bison B, et al (2012) Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade gliomas in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro-Oncology 14(10):1265–1284
Gnekow A, Kandels D, Walker D, Perilongo G, et al (2014) Abstracts from the sixteenth international symposium on pediatric neuro-oncology: a randomized trial of intensification of induction-chemotherapy within an 18 months treatment-strategy on tumor-response at 24 weeks and progression-free-survival in pediatric low grade glioma (LGG). Preliminary results of the SIOP-LGG-2004-Working Group. Neuro-Oncology 16:i60–i70. doi:10.1093/neuonc/nou073
Goodden J, Pizer B, Pettorini B, Williams D, Blair J, Didi M, et al (2014) The role of surgery in optic pathway/hypothalamic gliomas in children. J Neurosur Pediatr 13(1):1–12
Haapasalo J, Mennander A, Helen P, Haapasalo H, Isola J (2005) Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas. J Clin Pathol 58:263–268
Hashiba T, Izumoto S, Kagawa N, Suzuki T, Hashimoto N, Maruno M, Yoshimine T (2007) Expression of WT1 protein and correlation with cellular proliferation in glial tumors. Neurol Med Chir (Tokyo) 47(4):165–170
Hernaiz-Driever P, Von Hornstein S, Pietsch T, Kortmann R, Warmuth-Metz M, Emser A, Gnekow AK (2010) Natural history and management of low-grade glioma in NF1 children. J Neuro-Oncol 100(2):199–207
Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189–198
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system, 4th edn. IARC, Lyon, p. 309
Marcus KJ, Goumnerova L, Billett AL, et al (2005) Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys 61:374–379
Margraf LR, Gargan L, Butt Y, Raghunathan N, Bowers DC (2011) Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas—an assessment of 3 new variables in predicting clinical outcome. Neuro-Oncology 13:767–774
Maurizi P, Ruggiero A, Attinà G, Cefalo MG, Arlotta A, Riccardi R (2008) The prognostic role of Ki-67 in childhood low-grade glioma. Pediatr Med Chir 30(2):73–78
Merchant TE, Conklin HM, Wu S, et al (2009) Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol 27(22):3691–3697
Monje M, Graham Fisher P (2011) Neurosurgical complications following treatment of children with brain tumors. J Pediatr Rehabil Med 4(1):31–36
Mora J, Cruz O, Gala S, Navarro R (2007) Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin. Neuro-Oncology 9:39–46
Neervoort FW, Van Ouwerkerk W, Folkersma H, Kaspers G, Vandertop W (2010) Surgical morbidity of pediatric brain tumors: a single center audit. Childs Nerv Syst 26(11):1583–1592
Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64(6):479–489
Packer RJ, Ater J, Allen J, et al (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747–754
Palma L, Celli P, Mariottini A (2004) Long-term follow-up of childhood cerebellar astrocytomas after incomplete resection with particular reference to arrested growth or spontaneous tumor regression. Acta Neurochir 146:581–588
Pollack F et al (2002) Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med 346(6):420–427
Qaddoumi I, Sultan I, Gajjar A (2009) Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the surveillance, epidemiology, and end results database. Cancer 115:5761–5770
Qaddoumi I, Sultan Y, Broniscer A (2009) Pediatric low-grade gliomas and the need for new options for therapy: why and how? Cancer Biol Ther 8:4–10
RNTI-SEHOP, Registro Nacional de tumores en España – Sociedad Española de Hemato-Oncologia Pediátrica. 1980–2012. www.uv.es/rnti/index.html
Shaw EG, Wisoff JH (2003) Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro-Oncology 5:153–160
Sievert AJ, Fisher MJ (2009) Pediatric low-grade gliomas. J Child Neurol 24:1397–1408
Stokland T, Liu JF, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker DA (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro-Oncology 12:1257–1268
Terashima K, Chow K, Jones J, Ahern C, Jo E, Ellezam B, Paulino A, et al (2013) Long-term outcome of centrally located low-grade glioma in children. Cancer 119(14):2630–2638
Wisoff JH et al (2011) Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children’s Oncology Group. Neurosurgery 68(6):1548–1554 discussion 1554–5
Acknowledgments
We are grateful to our nursing and multidisciplinary staff for their support in patient care. We thank Daniel Cuadras and Sara Perez Jaume for their support in statistics (Fundació Sant Joan de Déu per la recerca). The authors also thank the institutional Biobank “Biobanc de l’ Hospital Materno-Infantil de Sant Joan de Déu per la recerca” as part of the “Red Temática de Biobancos Hospitalarios del ISCIII” and also Miss Sarah Buttler for her valuable help in the edition of this paper.
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Garzón, M., García-Fructuoso, G., Suñol, M. et al. Low-grade gliomas in children: single institutional experience in 198 cases. Childs Nerv Syst 31, 1447–1459 (2015). https://doi.org/10.1007/s00381-015-2800-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-015-2800-9